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Direct type I interferon (IFN) signaling on T cells is
necessary for the proper expansion, differentiation,
and survival of responding T cells following infection
with viruses prominently inducing type I IFN. The rea-
sons for the abortive response of T cells lacking the
type I IFN receptor (Ifnar1/) remain unclear. We
report here that Ifnar1/ T cells were highly suscep-
tible to natural killer (NK) cell-mediated killing in a
perforin-dependent manner. Depletion of NK cells
prior to lymphocytic choriomeningitis virus (LCMV)
infection completely restored the early expansion of
Ifnar1/ T cells. Ifnar1/ T cells had elevated
expression of natural cytotoxicity triggering receptor
1 (NCR1) ligands upon infection, rendering them
targets for NCR1 mediated NK cell attack. Thus,
direct sensing of type I IFNs by T cells protects
them fromNK cell killing by regulating the expression
of NCR1 ligands, thereby revealing a mechanism by
which T cells can evade the potent cytotoxic activity
of NK cells.
INTRODUCTION
Proper activation, expansion, and differentiation of T cells is crit-
ical for the clearance of viral infections and is dependent on three
key signals: antigen presentation, costimulation, and cytokine
signaling. The nature of the infecting pathogen determines which
cytokines serve as signal 3 cytokines, with the two most studied
being interleukin-12 (IL-12) and type I interferons (IFNs) (Aichele
et al., 2006; Keppler et al., 2009; Kolumam et al., 2005). T cell
responses are dependent on type I IFNs during lymphocytic
choriomeningitis virus (LCMV) infection, where the inability to
directly sense type I IFNs leads to curtailed expansion (Aichele
et al., 2006; Kolumam et al., 2005) and altered differentiation ofantiviral T cells (Wiesel et al., 2012). The cause(s) for the abortive
expansion of T cells lacking the type I IFN receptor (Ifnar1/) are
unknown and their identification is critical to understand the
regulation of T cell dynamics during acute viral infections.
In addition to their role as signal 3 cytokines for T cell activa-
tion, type I IFNs act on numerous cell types leading to the estab-
lishment of an antiviral state (Stark et al., 1998). Natural killer (NK)
cells can be activated directly by type I IFNs (Biron et al., 1984;
Gidlund et al., 1978). NK cells play a central role in the innate
immune response and contribute to the clearance of certain viral
infections and cancerous cells (French and Yokoyama, 2003;Wu
and Lanier, 2003), either via direct cytotoxic functions, via provi-
sion of inflammatory cytokines such as IFN-g, or via crosstalk to
antigen-presenting cells (APCs) and subsequent regulation of
T cells (Cook andWhitmire, 2013). NK cells recognize target cells
through an array of activating and inhibitory receptors (Cerwenka
and Lanier, 2001).When signals fromactivating ligands outweigh
those of inhibitory signals, NK cell effector functions are trig-
gered. Inhibitory ligands, such as major histocompatibility
complex (MHC) class I, are important for maintaining NK cell
self-tolerance and preventing autoimmunity (Yokoyama, 1995),
whereas activating ligands, such as the mouse cytomegalovirus
(MCMV) viral protein m157 recognized by Ly49H on NK cells are
important for protection against viral infection (Arase et al.,
2002). In addition to their direct role in viral clearance and control
of ‘‘altered’’ self cells, NK cells can regulate T cell responses in a
positive and negative manner. Such regulation can occur in an
indirect manner, for instance via the elimination of antigen-pre-
senting dendritic cells, having a negative impact on the induction
of T cell responses and the success of vaccination (Andrews
et al., 2010; Hayakawa et al., 2004). In a direct manner, NK cells
were shown to regulate T cell responses through cytokine secre-
tion or direct cytolysis, whereby NK cells can directly kill CD8+
and CD4+ T cells (Lang et al., 2012; Lu et al., 2007; Soderquest
et al., 2011;Waggoner et al., 2010, 2012, 2014), thereby affecting
the size of the antigen-specific T cell pool and the control of an
infection. Multiple NK cell ligands are proposed to play a role
in this killing process; blockade of the activating receptorImmunity 40, 961–973, June 19, 2014 ª2014 Elsevier Inc. 961
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NK Cells Kill Ifnar1/ T CellsNKG2D leads to enhanced CD8+ T cell responses in the context
of peptide vaccination (Soderquest et al., 2011) and high dose
LCMV infection (Lang et al., 2012), whereas expression of the
inhibitory ligands Qa1 and CD48 on T cells can confer protection
against NK cell mediated lysis (Lu et al., 2007; Waggoner et al.,
2010). What remains to be explained is whether and how
T cells can protect themselves from NK-cell-mediated killing.
In this study we sought to address these questions by identi-
fying the mechanisms responsible for the impaired expansion
of Ifnar1/ LCMV-specific CD8+ and CD4+ T cells during acute
LCMV infection. By performing a whole-genome gene-expres-
sion analysis, we found many molecules involved in cell death
being differentially regulated in Ifnar1/ LCMV-specific CD8+
T cells compared to their WT counterparts, among which were
multiple NKcell activating and inhibitory ligands. In vivo depletion
of NK cells revealed a key role for NK cells in the negative regu-
lation of Ifnar1/ T cells, with NK cell depletion during priming
leading to a complete recovery of the early Ifnar1/ T cell expan-
sion. We further found that NK cells selectively killed activated
Ifnar1/ T cells in a perforin-dependent manner via engagement
of natural cytotoxicity triggering receptor 1 (NCR1) ligands being
specifically upregulated on Ifnar1/ T cells. Our data establish a
mechanism whereby type I IFN signaling on activated T cells is
pivotal to protect them from NCR1-mediated NK cell attack.
RESULTS
Microarray Analysis Reveals Distinct Gene-Expression
Profiles in Ifnar1–/– and WT P14 Cells
To investigate the reason(s) for the compromised expansion of
CD8+ T cells lacking the ability to sense type I IFN during
LCMV infection, we performed a whole-genome microarray
comparing type I IFN receptor sufficient (WT) and deficient
(Ifnar1/) LCMV-specific CD8+ T cells. WT and Ifnar1/ T cell
receptor (TCR) transgenic CD8+ T cells specific for the LCMV
glycoprotein gp33–41 (P14) were cotransferred into naive
C57BL/6 (Bl6) mice followed by LCMV infection. To increase
the low Ifnar1/ P14 T cell numbers recovered following
LCMV infection, we utilized the previously described LCMV8.7
and vaccinia virus (VVG2) coinfection (Wiesel et al., 2011), where
the inflammatory environment is provided by the LCMV8.7
mutant, which is not recognized by P14 cells, and antigen is pro-
vided by the LCMV-GP recombinant VVG2. This setup leads to
greater expansion of both Ifnar1/ and WT P14 T cells
compared to LCMV, allowing for analysis of Ifnar1/ P14 cells
at early time points. Importantly, the ratio between Ifnar1/
and WT cells is comparable in the coinfection and single infec-
tion models (Figures 1A and 1B) and it has been previously
shown that there is no difference in the phenotype or differentia-
tion of P14 cells in the two infection models (Wiesel et al., 2012).
For microarray analysis, WT and Ifnar1/ P14 cells were sorted
to high purity based on expression of the congenic markers
Ly5.1 (WT) and Thy1.1 (Ifnar1/) at day 3 post coinfection, the
time point corresponding to the peak of Ifnar1/ P14 expansion
(data not shown) (Figure 1C). Analysis of genes more than 2-fold
differentially regulated revealed 631 genes that were differen-
tially expressed in activated Ifnar1/ andWT P14 cells. Of these
genes, 374 were upregulated in Ifnar1/ compared to WT P14
cells and 257 were downregulated. Pathway analysis of the962 Immunity 40, 961–973, June 19, 2014 ª2014 Elsevier Inc.631 genes revealed that many genes grouped together into
distinct functional pathways (Figure 1D). The pathways with the
greatest number of differentially expressed genes were those
related to signaling and signal transduction, metabolic pro-
cesses, cell death and apoptosis, and IFN signaling. Of particular
interest were those genes associated with cell death regulation,
as these could be of direct relevance for the abortive expansion
of Ifnar1/ P14 cells. Further analysis revealed differential
expression of many genes encoding ligands for NK cell acti-
vating or inhibitory receptors (Figure 1E). In combination with
recent reports demonstrating NK cell regulation of T cell re-
sponses, we decided to further examine a potential role of NK
cells in the negative regulation of Ifnar1/ P14 cell expansion.
NK Cell Depletion Restores Ifnar1–/– P14 Cell Expansion
To test for a regulatory role of NK cells, we cotransferredWT and
Ifnar1/ P14 cells into NK cell depleted (aNK1.1) or undepleted
(Bl6) mice followed by acute LCMV strain WE (LCMV-WE) infec-
tion. Depletion of NK cells led to the complete recovery of
Ifnar1/ P14 cell expansion at day 4 postinfection (p.i.), both
in percentage and total cell numbers (Figures 2A and 2B). This
20-fold increase in expansion was observed in spleen and
lymph nodes (data not shown). Consistent with previous reports
(Lang et al., 2012; Lu et al., 2007; Soderquest et al., 2011; Wagg-
oner et al., 2012; Waggoner et al., 2010), we observed a moder-
ate increase (1.5-fold) in expansion of WT P14 cells in NK-cell-
depleted mice. Furthermore, previous reports found that
Ifnar1/CD4+ T cells also show a strong reduction in expansion
following LCMV infection (Havenar-Daughton et al., 2006).
Therefore, we generated Ifnar1/ Smarta (SM) cells, being
transgenic CD4+ T cells specific for the LCMV glycoprotein
gp61–80 epitope. Cotransfer of WT and Ifnar1
/ SM cells into
NK-cell-depleted mice followed by LCMV infection revealed
that Ifnar1/SM cell expansion could also be completely recov-
ered to WT amounts by NK cell depletion (Figures 2A and 2B). In
addition, Ifnar1/ P14 cell expansion was also recovered with
the anti-Asialo GM1 NK-cell-depleting antibody, which targets
an epitope not expressed on NKT or T cells (see Figure S1 avail-
able online). Analysis of P14 cell function at day 4 p.i. revealed
that NK cell depletion had no significant effect on the activation
(CD44) or effector functions of WT and Ifnar1/ P14 cells, as
shown by percentage of IFN-g, perforin, and granzyme B-posi-
tive T cells (Figure 2C). Furthermore, comparing the global
gene-expression profiles of P14 cells isolated from Bl6 and
NK-cell-depleted mice by cluster analysis revealed that NK cell
depletion had little effect on the overall expression profile of
WT or Ifnar1/ P14 cells (Figure 2D).
Next, we addressed the question of whether naive Ifnar1/
P14 cells are also sensitive to NK-cell-mediated killing. To this
end, we infected mice with LCMV8.7, following cotransfer with
WT and Ifnar1/ P14 cells. In this setting, P14 cells remain anti-
gen inexperienced but the inflammatory environment andNK cell
activation remains the same as in LCMV-WE infection. WT and
Ifnar1/ P14 cell numbers were comparable during LCMV8.7
infection with or without NK cell depletion (Figure 2E), indicating
that T cells need to be activated for negative regulation by NK
cells. Finally, NK cell depletion could also recover Ifnar1/ P14
cell expansion to the level of WT P14 cells during infection with
vesicular stomatitis virus expressing the LCMV glycoprotein
Figure 1. Microarray Analysis Reveals Distinct Gene-Expression Profiles in Ifnar1–/– and WT P14 Cells
(A) and (B) LCMV-WE infection and LCMV8.7 + VVG2 coinfection following cotransfer of 106 WT and Ifnar1/ P14 cells. (A) Representative flow cytometry dot
plots of WT (Ly5.1+) and Ifnar1/ (Thy1.1+) P14 cells 3 days p.i. in the spleen, numbers indicate the percentage of total CD8+ T cells. (B) Total P14 cell numbers in
the spleen 3 days p.i. Data are shown as mean ± SEM of n = 12 mice pooled from three independent experiments. ***p < 0.001 (unpaired two-tailed t test).
(C) Experimental setup for microarray analysis; WT and Ifnar1/ P14 cells were cotransferred into naive Bl6 mice followed by LCMV8.7 + VVG2 coinfection.
3 days p.i. WT (Ly5.1+) and Ifnar1/ (Thy1.1+) P14 cells were sorted to purity and used for microarray analysis.
(D) Pie chart representing functional pathways enriched among genes more than 2-fold differentially expressed between WT and Ifnar1/ P14 cells. Numbers
represent the percentage of genes found in the respective pathways.
(E) Heatmap expression pattern of genes involved in NK cell activation and inhibition. Expression ranges from low expression (green) to high expression (red).
Each box represents a group from the microarray analysis; each group was performed in triplicates.
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NK Cells Kill Ifnar1/ T Cells(VSVGP), another infection associated with high amounts of
type I IFNs (Figure 2F). Taken together, we found that both
CD8+ and CD4+ T cells lacking the ability to sense type I IFNs
are highly susceptible to negative regulation by NK cells.
NK Cell Depletion Leads to Enhanced Memory Ifnar1–/–
P14 Cell Formation
NK cell depletion leads to a full recovery of expansion of Ifnar1/
P14 cells up to day 4 p.i., but at day 7 p.i., Ifnar1/ P14 cells
exhibited reduced expansion compared to WT P14 cells, which
could partially be recovered by NK cell depletion (Figures 3A
and 3B). Nonetheless, NK cell depletion led to a 100-fold
increase in total Ifnar1/ P14 cell numbers compared to unde-
pleted controls. Similar to Ifnar1/ P14 cells, Ifnar1/ SM cells
also exhibited a partial recovery of expansion at day 7 p.i. when
NK cells were depleted (Figures 3A and 3B). Comparable resultswere obtainedwith aNK1.1 and anti-Asialo-GM1 targetedNK cell
depletion (Figure S2). To examine the effect of NK cells on the
endogenous Ifnar1/ T cell response, we utilized mice in which
T cells specifically lack the type I IFN receptor (Cd4creIfnar1flox/flox)
(Kamphuis et al., 2006). We found a substantial recovery in the
expansion of total activated (CD44hi) or gp33 tetramer and
np396 tetramer-specific CD8+ T cells in NK-cell-depleted
(aNK1.1) Cd4creIfnar1flox/flox mice compared to undepleted (Ø)
mice at day 7 p.i. (Figure 3C). As previously reported, Ifnar1/
P14 cells failed to differentiate into short-lived effector cells
(SLECs) and were skewed toward a memory precursor effector
cell (MPEC) phenotype. Depletion of NK cells had no effect on
acquisition of this differential phenotype betweenWT or Ifnar1/
P14 cells (Figure 3D). Next, we examined memory formation of
WT and Ifnar1/ P14 cells with and without NK cell depletion.
Depletion of NK cells during priming led to a substantial increaseImmunity 40, 961–973, June 19, 2014 ª2014 Elsevier Inc. 963
Figure 2. NK Cell Depletion Restores Ifnar1–/– P14 Cell Expansion
(A and B) Percentage and total T cell numbers of WT and Ifnar1/ P14 or SM cells in LCMV infected NK cell depleted (aNK1.1) or undepleted (Bl6) mice at day 4
p.i. Naive mice received cell transfers but were left uninfected. (A) Representative flow cytometry dot plots pregated on CD8+ (top row) or CD4+ (bottom row)
T cells. Numbers represent the percentage of total CD8+ or CD4+ T cells in the spleen. (B) Total cell numbers of WT and Ifnar1/ P14 and SM cells 4 days p.i.
(C) Functionality of T cells fromNK cell depleted (aNK1.1) and undepleted (Bl6) mice 4 days p.i. Shown is the percentage of cells positive for the indicated marker.
No significant differences were found when comparing activation markers of Ifnar1/ P14 cells from Bl6 and NK-cell-depleted mice.
(D) Hierarchical clustering of overall gene-expression patterns of WT and Ifnar1/ P14 cells from undepleted (Bl6) and depleted (aNK) mice.
(E) Day 4 p.i. cell numbers of WT and Ifnar1/ P14 cells in the spleen as in (A) from mice infected with LCMV-WE or LCMV8.7.
(F) Total number of P14 cells 3 days following VSVGP infection. (B, D–F) Data shown aremean ± SEMof n = 4mice representative of at least three experiments. ns,
not significant; *p < 0.05; **p < 0.01; ***p < 0.001 (unpaired two-tailed t test). See also Figure S1.
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NK Cells Kill Ifnar1/ T Cellsin the percentage and number (Figures 3E and 3F) of Ifnar1/
memory P14 cells compared to the undepleted situation. Pheno-
typically, NK cell depletion during priming had no effect on the
differentiation of memory cells into central and effector memory
cells at day 80 p.i. and VVG2 challenge revealed that WT and
Ifnar1/ P14 cells were equally functional with respect to recall
potential and exertion of effector functions, regardless of whether
they hadbeenprimed in the presence or absence ofNK cells (Fig-964 Immunity 40, 961–973, June 19, 2014 ª2014 Elsevier Inc.ure S3). Taken together, NK cell depletion leads to a partial recov-
ery of Ifnar1/ T cell expansion at day 7 p.i. and substantially
increased formation of functional memory cells.
Memory Ifnar1–/– P14 Cell Expansion Is Curtailed by NK
Cells during LCMV Infection
Similar to primary T cell responses, memory recall of CD8+ T cells
is alsodependent on signal 3 cytokines asmemory Ifnar1/CD8+
Figure 3. NK Cell Depletion Leads to Enhanced Memory Ifnar1–/– P14 Cell Formation
(A and B) Percentage and total T cell numbers of WT and Ifnar1/ P14 or SM cells in NK cell depleted (aNK1.1) or undepleted (Bl6) mice at day 7 p.i. Naive mice
received cell cotransfers but were left uninfected. (A) Representative flow cytometry dot plots pregated on CD8+ (top row) or CD4+ (bottom row) T cells are shown.
Numbers represent the percentage of total CD8+ or CD4+ T cells in the spleen. (B) Total numbers of WT and Ifnar1/ P14 and SM cells 7 days post LCMV
infection.
(C) WT (Bl6) or Cd4creIfnar1flox/flox mice were depleted of NK cells (aNK1.1) or left un-depleted (Ø) and infected with LCMV-WE. At day 7 p.i., total activated CD8+
T cells were analyzed by gating on CD44hi CD8+ cells. Gp33 and np396-specific responses were analyzed by tetramer staining. Shown are the total numbers of
the indicated cells in the spleen. Data shown are representative of n = 4 mice. ns, not significant; *p < 0.05; **p < 0.01 (unpaired two-tailed t test).
(D) Differentiation phenotype of WT and Ifnar1/ P14 cells as in (A) in NK cell depleted (aNK1.1) and undepleted (Bl6) mice, shown are the percentage of short-
lived effector cells (CD44hi, KLRG1hi, CD127lo) and memory precursor effector cells (CD44hi, KLRG1lo, CD127hi) among WT or Ifnar1/ P14 cells 7 days post
LCMV infection. Data shown are mean ± SEM of n = 12 mice pooled from three independent experiments. ns, not significant (unpaired two-tailed t test).
(E and F) Time course analysis of WT and Ifnar1/ P14 cells in NK cell depleted (aNK) and undepleted (Bl6) mice following LCMV infection. (E) Percentage of P14
cells among total CD8+ T cells in blood. (F) Total P14 cell number day 80 p.i. in the spleen of undepleted (Bl6) and NK-cell-depleted (aNK1.1) mice. (B, D–F) Data
shown are mean ± SEM of n = 4 mice representative of three independent experiments. ns, not significant; **p < 0.01 (unpaired two-tailed t test). See also
Figure S2.
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NK Cells Kill Ifnar1/ T CellsT cells show greatly reduced recall expansion during LCMV infec-
tion (Keppler and Aichele, 2011). Therefore, we examinedwhether
thememory response to LCMV is also negatively regulated by NKcells in the absence of type I IFN signaling on CD8+ T cells. To
generate memory P14 cells, we cotransfected WT and Ifnar1/
P14 cells into naive mice followed by VVG2 infection (Figure 4A).Immunity 40, 961–973, June 19, 2014 ª2014 Elsevier Inc. 965
Figure 4. Memory Ifnar1–/– P14 Cell Expansion Is Curtailed by NK Cells during LCMV Infection
(A) WT and Ifnar1/memory P14 cells were generated after infection with VVG2. At day 80 p.i., CD8+ T cells were MACS purified and transferred into naive NK-
cell-depleted (aNK1.1) or undepleted (Bl6) hosts followed by challenge with LCMV or VVG2.
(B) Phenotypic analysis of P14memory T cells at day 80 post VVG2 infection. Flow cytometry dot plots and histograms of the indicatedmarkers are shown and are
representative of three independent experiments with n = 4 mice.
(C) Fold expansion of WT and Ifnar1/ P14 cells at day 4 and (D) day 7 post challenge. (C and D) Data shown are mean ± SEM of n = 12 mice pooled from three
independent experiments. ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001 (unpaired two-tailed t test). See also Figure S3.
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NK Cells Kill Ifnar1/ T CellsAt day 80 p.i., WT and Ifnar1/ P14 cells had differentiated into
phenotypically equivalent memory cells (Figure 4B). At this time
point, memory CD8+ T cells were purified and transferred into
either NK cell depleted or undepletedmice, followed by challenge
with LCMV-WE or VVG2. At day 4 postchallenge, analysis of T cell
expansion in the blood revealed reduced expansion of Ifnar1/
P14 cells during LCMV challenge, which could be completely
restored by NK cell depletion during the challenge phase (Fig-
ure 4C). At day 7 post LCMV challenge, as during the primary
response, NK cell depletion led to a partial recovery of Ifnar1/
P14cell expansion (Figure 4D). In summary, bothprimary and sec-
ondary CD8+ T cell responses to LCMV are dependent on type I
IFN signaling, and depletion of NK cells leads to enhanced expan-
sion of both naive and memory Ifnar1/ P14 cells.
Negative Regulation of Ifnar1–/– T Cell Expansion by NK
Cells Is Perforin Dependent
To investigate the mechanisms of how this negative regulation
occurs, we focused on a potential role of perforin-mediated966 Immunity 40, 961–973, June 19, 2014 ª2014 Elsevier Inc.cytotoxicity. To this end, we cotransferred WT and Ifnar1/
P14 cells into perforin-deficient (Prf1/) mice followed by
LCMV infection. Analysis at day 4 p.i. revealed that Ifnar1/
P14 cell priming in Prf1/ mice led to the complete recovery
of early expansion (Figures 5A and 5B). The expansion of
Ifnar1/ P14 cells in Prf1/ mice was comparable to NK cell
depletion in Bl6 mice, and NK cell depletion in Prf1/ mice
had no additional effect (Figure S4). Furthermore, at day 7 p.i.,
expansion of Ifnar1/P14 cells inPrf1/micewas also partially
recovered (Figures 5A and 5B), in analogy to NK-cell-depleted
Bl6 hosts. Similar results were obtained when Ifnar1/ SM cells
were transferred into Prf1/ mice, with complete recovery of
Ifnar1/ SM cell expansion by day 4 p.i. and partial recovery
by day 7 in NK-cell-depleted hosts, and a full recovery in
Prf1/ mice (Figures 5C and 5D). The reduced expansion of
WT SM cells at day 7 in Prf1/ compared to Bl6 mice is due
to increased viral burden in the former, as LCMV control is
dependent on perforin-mediated CD8+ T cell effector function.
The total number of Ifnar1/ SM cells was comparable between
Figure 5. Negative Regulation of Ifnar1–/– T Cell Expansion by NK Cells Is Perforin Dependent
(A–D) Cotransfer of WT and Ifnar1/ P14 or SM cells into NK-cell-depleted (aNK1.1), perforin-deficient (Prf1/), or undepleted (Bl6) mice followed by LCMV
infection. On day 4 and day 7 p.i., the percentage and total cell numbers were determined. (A andC) Representative flow cytometry dot plots pregated onCD8+ (A)
or CD4+ (C) T cells, numbers represent the percentage of total CD8+ (A) or CD4+ (C) T cells in the spleen. (B and D) Total number of WT and Ifnar1/ P14 or SM
cells at day 4 (top) and day 7 (bottom) post LCMV infection. Data shown are mean ± SEM of n = 12 mice pooled from three experiments. ns, not significant; **p <
0.01; ***p < 0.001 (unpaired two-tailed t test). See also Figure S4.
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NK Cells Kill Ifnar1/ T CellsPrf1/ mice and NK-cell-depleted Bl6 mice. Thus, our results
demonstrate that the early negative regulation of Ifnar1/
T cells by NK cells is perforin dependent, implicating a direct
killing mechanism.NK Cells Preferentially Kill Ifnar1–/– T Cells
Next, we investigated whether NK cells were preferentially killing
Ifnar1/ P14 cells. To demonstrate direct killing of CD8+ T cells
by NK cells, we established an in vivo killer assay. WT andImmunity 40, 961–973, June 19, 2014 ª2014 Elsevier Inc. 967
Figure 6. NK Cells Preferentially Kill
Ifnar1–/– T Cells
(A) Experimental setup of the in vivo killer assay
used in (B) and (C). T cell donors were NK cell
depleted and cotransferred WT and Ifnar1/ P14
cells followed by LCMV8.7 + VVG2 coinfection.
Day 3 p.i. P14 cells were isolated, MACS purified,
and transferred into LCMV-WE infection matched
undepleted (Bl6) or NK-cell-depleted (aNK1.1)
hosts. P14 cell recovery was determined 6 hr later.
(B) WT and Ifnar1/ P14 cell recovery relative to
the amount recovered in naive mice. Data shown
are mean ± SEM of n = 12 mice pooled from three
experiments. ns, not significant; *p < 0.05; **p <
0.01 (unpaired two-tailed t test).
(C) Ratio of Ifnar1/ to WT P14 cells from the
indicated hosts, data shown are mean ± SEM of
n = 4 mice representative of three independent
experiments. ns, not significant; ***p < 0.001
(unpaired two-tailed t test).
(D) Experimental setup of the ex vivo killer assay
used in (E). T cell donors were NK cell depleted
and cotransferred WT and Ifnar1/ P14 cells
followed by LCMV8.7 + VVG2 coinfection. At day 3
p.i. WT (Ly5.1+) and Ifnar1/ (Thy1.1+) cells were
sorted to high purity. NK cells were isolated from
LCMV-WE infected mice at day 2 p.i. and MACS
purified. We placed 2 3 104 WT or Ifnar1/ P14
cells in triplicates together with the indicated
amounts of NK cells for 6 hr followed by flow
cytometric analysis.
(E) The percentage of apoptotic Annexin V and
7-AAD double positive cells is depicted as per-
centage of total WT or Ifnar1/ P14 cells. Data
shown are mean ± SEM of n = 3 representative
from at least three experiments ns, not significant;
*p < 0.05; **p < 0.01; ***p < 0.001 (unpaired two-
tailed t test).
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NK Cells Kill Ifnar1/ T CellsIfnar1/ P14 cells were activated in vivo by VVG2 and LCMV8.7
coinfection, to increase T cell recovery. Activated CD8+ T cells
were isolated at day 3 p.i. and transferred into naive or infec-
tion-matched hosts, which had been depleted of NK cells or
left untreated (Figure 6A). After 6 hr, spleens from host mice
were isolated and P14 cell recovery was analyzed. The number
of recovered P14 cells in infected hosts was normalized to naive
hosts and the percentage of recovery was determined (Fig-
ure 6B). We found a significant reduction in the recovery of
Ifnar1/ P14 cells in undepleted hosts compared to WT P14968 Immunity 40, 961–973, June 19, 2014 ª2014 Elsevier Inc.cells, and this reduced recovery was
abolished by NK cell depletion. Also, by
examining the ratio of Ifnar1/ to WT
P14 cells in the different hosts, we found
a specific reduction in Ifnar1/ P14 cells
in undepleted hosts, whichwas abolished
by NK cell depletion (Figure 6C), indi-
cating preferential in vivo killing of
Ifnar1/ compared to WT P14 cells.
Next, we developed an ex vivo killer assay
to directly examine the killing of P14 cells
by NK cells. WT and Ifnar1/ P14 cells
were activated in NK cell depleted micein vivo by coinfection with VVG2 and LCMV8.7. At day 3 p.i.,
WT and Ifnar1/ P14 cells were sorted to high purity and placed
together with day 2 in vivo LCMV activated NK cells (Figure 6D).
Following a 6 hr incubation period, T cell killing was visualized by
staining with 7-AAD and Annexin V, where double-positive cells
represent late apoptotic cells. We observed a strong increase in
the percentage of double-positive Ifnar1/ P14 cells with
increasing effector NK to CD8+ T cell target ratios (Figure 6E).
This increase in apoptotic Ifnar1/ P14 cells was reduced to
background amounts in the presence of naive NK cells or
Figure 7. Activated Ifnar1–/– CD8+ T Cells Are Killed by NK Cells in a NCR1-Dependent Manner
(A) Quantitative real-time PCR of the indicated NK cell activating or inhibitory ligands. RNA was isolated from WT and Ifnar1/ P14 cells on day 4 post LCMV
infection. Shown is the fold increase in expression in Ifnar1/ P14 cells compared to WT P14 cells.
(B) Ex vivo killer assay as described in Figure 6D in combination with blocking reagents for the indicated molecules. Shown is the percentage of Annexin V and
7-AAD double-positive cells among the total P14 or Ifnar1/ P14 cells. Data shown are mean ± SEM of n = 12 pooled from at least three experiments.
(C and D) NCR1 ligand expression on Ifnar1/ and WT P14 and SM cells, stained by NCR1-IgG fusion protein on day 4 post LCMV infection. (C) Overlay his-
togram of WT (dashed, shaded line) and Ifnar1/ (black line) P14 cells (left) and WT (dashed, shaded line) and Ifnar1/ (black) SM cells (right) stained with 1 mg
NCR1-IgG fusion protein. (D) Summary graph of the percentage NCR1 ligand positive P14 and SM cells (C and D) Data shown are mean ± SEM of n = 4
representative from at least three experiments.
(E and F) Cotransfer of WT and Ifnar1/ P14 or SM cells into NCR1 deficient (Ncr1iCre/iCre), littermate heterozygous controls (Ncr1iCre/WT), NK1.1-depleted
(aNK1.1), or undepleted (Bl6) mice followed by LCMV-WE infection. On day 4 p.i., total cell numbers were determined. (E) Total numbers of P14 cells. Data shown
are mean ± SEM of n = 12 mice from three pooled independent experiments. (F) Total numbers of SM cells. Data shown are mean ± SEM of n = 8 mice from two
pooled independent experiments. ns, not significant; **p < 0.01; ***p < 0.001 (unpaired two-tailed t test). See also Figure S5.
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increase of apoptotic Ifnar1/ P14 cells but no increase in
apoptotic WT P14 cells, we concluded that Ifnar1/ P14 cells
are specifically rendered susceptible to NK cell mediated killing,
whereas T cells that can sense type I IFNs are protected.
Activated Ifnar1–/– CD8+ T Cells Are Killed by NK Cells in
an NCR1-Dependent Manner
Because Ifnar1/ P14 cells were more susceptible to NK-cell-
mediated killing, we examined the mechanisms of how Ifnar1/P14 cells are specifically recognized by NK cells. From the
microarray analysis, we found differential regulation of various
molecules involved in NK cell activation or inhibition. To recon-
firm differential expression of activating or inhibiting ligands for
NK cells, we analyzed expression of a selection of ligands by
quantitative real-time PCR (Figure 7A). Among the reconfirmed
ligands we found a 3-fold upregulation of the NKG2D activating
ligand Mult-1 (Carayannopoulos et al., 2002) on Ifnar1/
compared toWT P14 cells. Ifnar1/ P14 cells had a 2-fold upre-
gulation of Clec2i (Clr-g), the activating ligand for NKR-P1FImmunity 40, 961–973, June 19, 2014 ª2014 Elsevier Inc. 969
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NK Cells Kill Ifnar1/ T Cells(Iizuka et al., 2003), and a 3-fold upregulation of CD99, which has
been shown to have both activating and inhibitory functions, de-
pending on the receptor it binds to (Shiratori et al., 2004). The
inhibitory ligand CD48, which binds 2B4 (Waggoner et al.,
2010), was expressed at similar amounts on Ifnar1/ and WT
P14 cells. Strongly upregulated on Ifnar1/ compared to WT
P14 cells was the adhesion molecule VCAM-1, but no difference
was seen in the expression of the activating ligand CD155 (Bot-
tino et al., 2003). Of note, the classical inhibitory ligand, MHC
class I, was not differentially expressed on WT or Ifnar1/ P14
cells (data not shown). To investigate a possible role of those
activating ligands, we utilized the ex vivo killer assay in combina-
tion with various blocking antibodies. Blocking of NKG2D,
VCAM-1, CD48, or CD7, a ligand involved in T cell apoptosis
(Pace et al., 2000), had no impact on preferential NK-cell-medi-
ated killing of Ifnar1/ compared to WT P14 cells (Figure 7B).
Confirming the ex vivo killer analysis, we found no role for
NKG2D in vivo when cotransferring WT and Ifnar1/ P14 cells
into Klrk1/mice followed by LCMV infection (data not shown).
We found that in vitro blocking of the NK-cell-activating receptor
NCR1 led to a complete abrogation of apoptosis induction in
Ifnar1/ P14 cells. Consequently, we examined the expression
of NCR1 ligands on WT and Ifnar1/ P14 cells at day 4 p.i. by
using an NCR1-immunoglobulin G (IgG) fusion protein, recog-
nizing the unknown cellular NCR1 ligands (Mandelboim et al.,
2001). NCR1-IgG fusion protein staining revealed increased
expression of NCR1 ligands on Ifnar1/ compared to WT P14
cells following LCMV infection, where around 40% of Ifnar1/
cells expressed NCR1 ligands (Figures 7C and 7D). Following
infection with VVG2, Ifnar1/ P14 cells expressed NCR1
ligands to comparable amounts as WT P14 cells during LCMV
infection (data not shown), indicating that the inflammatory envi-
ronment associated with VV could possibly compensate for the
lack of type I IFN signaling to protect the T cells from expressing
NCR1 ligands. Because Ifnar1/ CD4+ Smarta cells were also
killed in an NK cell-dependent manner, we examined the NCR1
ligand expression on WT and Ifnar1/ SM cells 4 days after
LCMV infection. Similar to Ifnar1/ P14 cells, we found an
increased expression of NCR1 ligands on Ifnar1/ compared
to WT SM cells (Figures 7C and 7D). Additionally, by using
Cd4creIfnar1flox/flox mice, which lack Ifnar1 expression specif-
ically on T cells, we found that endogenous T cells specific for
gp33 and np396 also showed an increased expression of
NCR1 ligands on their surface at day 7 p.i. (Figure S5A). Further-
more, infection with LCMV8.7 following cotransfer of WT and
Ifnar1/ P14 cells revealed that the upregulation of NCR1
ligands on Ifnar1/ P14 cells is antigen dependent, because
no increase in the expression of NCR1 ligands in Ifnar1/ P14
cells was seen upon LCMV8.7 infection (Figure S5B).
To functionally test the role of NCR1 in vivo, we cotransferred
WT and Ifnar1/ P14 cells into Ncr1icre/icre mice, which exhibit
impairment of NCR1 expression, followed by LCMV infection.
At four days p.i., we found a significant recovery of Ifnar1/
P14 cell expansion compared to the expansion in WT hosts or
heterozygous Ncr1icre/WT mice, despite the reported hyper-
activity of NK cells in Ncr1icre/icre mice (Narni-Mancinelli et al.,
2012) (Figure 7E). This recovery in expansion of Ifnar1/ P14
cells was comparable to NK-cell-depleted Bl6 hosts, indicating
a strong role for NCR1-dependent killing of Ifnar1/ T cells970 Immunity 40, 961–973, June 19, 2014 ª2014 Elsevier Inc.in vivo. Similarly, following transfer of WT and Ifnar1/ SM cells
into Ncr1icre/icre mice, followed by LCMV infection, we found that
the expansion of Ifnar1/ SM cells could also be recovered,
similar to NK-cell-depleted Bl6 mice (Figure 7F). Taken together,
the recovery of Ifnar1/ P14 and SM cell expansion in NCR1-
deficient mice, together with the results from ex vivo NCR1
blocking in NK-cell-mediated T cell killing assays, led us to
conclude that activated NK cells recognize Ifnar1/ T cells via
increased NCR1 ligand expression, culminating in perforin-
dependent killing of T cells that lack the ability to sense type I
interferons.
DISCUSSION
This study demonstrates that T cells lacking the ability to sense
type I IFNswere highly susceptible to elimination byNK cells dur-
ing the early phase of LCMV infection. Previous findings have
demonstrated that T cells can be recognized and killed by NK
cells in a perforin-dependent manner, but the conclusions and
mechanisms are controversial. It has been proposed that NK
cells can act as rheostats by killing CD4+ T cells and thereby indi-
rectly affecting the CD8+ T cell response (Waggoner et al., 2012).
Other groups have found that CD8+ T cells themselves can be
direct targets for NK cell mediated killing (Lang et al., 2012;
Soderquest et al., 2011). Our results complement these previous
findings and indicate that both CD8+ and CD4+ T cells could be
directly killed by NK cells following LCMV infection. Importantly,
our results add to these previous observations by revealing a
mechanism by which T cells can protect themselves from nega-
tive regulation by NK cells via direct sensing of type I IFNs. In line
with previous reports, we found that WT T cells were modestly
increased following NK cell depletion, whereas the massively
curtailed Ifnar1/ T cell expansion was greatly increased
(20 fold) following NK cell depletion.
Previous reports revealed several different mechanisms by
which regulation of T cell responses by NK cells can occur. It
has been shown that NK cells can have an indirect effect on
the T cell response by limiting the availability of APCs, such as
duringMCMV infectionwhen infected APCs can be directly killed
by NK cells (Andrews et al., 2010). However, we found no differ-
ences in dendritic cell (DC) numbers or functionality comparing
DCs from NK-cell-depleted or undepleted mice (Figure S6).
Acting in a direct manner, NK cells have been found to directly
recognize T cells via various activating and inhibitory ligands.
While some reports indicate a role for NKG2D-dependent recog-
nition and killing of CD8+ T cells (Lang et al., 2012; Soderquest
et al., 2011), others found no involvement for NKG2D-dependent
activation of NK cells (Waggoner et al., 2012). Our findings also
indicated no role for NKG2D, despite the detected upregulation
of Mult-1 on Ifnar1/ P14 cells. In line with the previous finding
that Qa1 expression on T cells can protect them from NK cell
mediated killing (Lu et al., 2007), we found a modest increase
in expression of Qa1 on WT compared to Ifnar1/ P14 cells
by microarray analysis. Whether or not this differential regulation
of Qa1 expression on WT and Ifnar1/ T cells has any physio-
logical consequence remains to be addressed. We have found
that Ifnar1/ T cells could be specifically recognized and elimi-
nated by NK cells in an NCR1-dependent manner, demon-
strating a prominent involvement of NCR1 ligand expression
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improperly activated T cells and eliminate them. Our data clearly
indicate that type I IFN signaling on T cells protects them from
NK-cell-mediated killing by regulating the balance of activating
and inhibitory signals to NK cells with a dominant contribution
of NCR1 ligands.
The finding that NCR1 ligands are upregulated on Ifnar1/
T cells following LCMV infection implies that type I IFNs some-
how block the upregulation of NCR1 ligands following activation,
implicating the possibility that NCR1 ligand upregulation is a
default program induced after T cell activation and that addi-
tional cytokine signaling is necessary to block its upregulation.
The finding that Ifnar1/ P14 cells did not upregulate NCR1
ligands following VVG2 infection leads to the possibility that
the inflammatory environment associated with a VV infection
could compensate for the lack of type I IFN signaling and thereby
protect T cells from upregulating NCR1 ligands and becoming
targets for NK cell killing. Because some redundancy between
the signal 3 cytokines IL-12 and type I IFN has been demon-
strated for expansion and differentiation of T cells (Curtsinger
et al., 2005), it is possible that IL-12 signaling on Ifnar1/ P14
cells following VVG2 infection can suppress the upregulation of
NCR1 ligands and thereby protect the activated T cells. How-
ever, further studies need to be performed to address this
hypothesis.
NCR1 activation on NK cells was shown to play an important
role in various viral infections; Ncr1/ mice, despite normal
in vitro killing of tumor cells, are more susceptible to lethal influ-
enza infection (Gazit et al., 2006) due to the ability of NK cells to
directly recognize and eliminate influenza infected cells (Mandel-
boim et al., 2001). Furthermore, in humans, low expression of
NCR1 has been associated with the persistent infections hepati-
tis C (Nattermann et al., 2006) and HIV (De Maria et al., 2003),
leading to the speculation that hosts might downregulate the
expression of NCR1 on NK cells to protect antiviral T cells from
elimination in a setting of persistent antigen exposure with low
abundance of signal 3 cytokines. It will be interesting to experi-
mentally address such a hypothesis in future studies. Our find-
ings expand on the role of NCR1 activation of NK cells and
demonstrate that in addition to its role in direct viral clearance
it also has a potent regulatory role on T cell expansion.
Despite the decisive role found for NK cells in the regulation of
Ifnar1/ T cell expansion at early time points, at the peak of T cell
expansion (day 7) Ifnar1/ T cell numbers were reduced
compared toWT T cells, which was independent of NK cell regu-
lation. These findings demonstrate that type I IFN signaling has
additional roles in the expansion of T cells. This could be due to
type I IFN-dependent regulation of other cytokine receptors
such as IL-7R and IL-15R, which both have important roles in
T cell survival (Schluns and Lefranc¸ois, 2003). In addition, the
inability of Ifnar1/ T cells to differentiate into SLECs can affect
the overall clonal burst size, because this population of cells with
greater ability to expand (Sarkar et al., 2008) is missing from the
Ifnar1/ T cell pool. In line with this, our microarray data indicate
that many cellular pathways involved in cell survival and cell divi-
sion are differentially regulated in Ifnar1/ P14 cells, indicating
that type I IFN signaling could imprint WT P14 cells for better sur-
vival and expansion. In linewith this reasoning, it has been shown
that type I IFN is important for T cell survival (Marrack et al., 1999),and both signal 3 cytokines IL-12 and type I IFN have been found
to induce chromatin remodeling inCD8+T cells, leading to a com-
plex gene regulation program that promotes survival and expan-
sion of CD8+ T cells (Agarwal et al., 2009).
In conclusion, we demonstrate that NK-cell-mediated killing of
improperly activated T cells is responsible for the abortive expan-
sion of Ifnar1/ T cells early after LCMV infection and also after
VSV infection, both infections being dominated by a biased
type I IFN milieu. The results lend support to a scenario in which
activated T cells need to efficiently safeguard themselves against
NK-cell-mediated cytotoxicity, and this protection is afforded by
type I IFN-driven inhibition of NCR1 ligand expression.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, Prf1/mice (Ka¨gi et al., 1994), P14 transgenic (Ly5.1+) mice (Pircher
et al., 1990), Ifnar1/ P14 mice (Thy1.1+), SM transgenic (Ly5.1+) mice
(Oxenius et al., 1998), and Ifnar1/ SM mice (Thy1.1+) were housed
and bred in specific pathogen-free facilities. Ncr1icre/icre genetically tar-
geted mice (Narni-Mancinelli et al., 2012) were generated by breeding
Ncr1icre mice to homozygosity (Narni-Mancinelli et al., 2011). T-cell-specific
Ifnar1/mice (Cd4creIfnar1flox/flox) mice were a kind gift from Professor Ulrich
Kalinke. All animals were used at 6 to 12 weeks of age. All animal experiments
have been performed in accordance with institutional policies and have been
reviewed by the cantonal veterinary office.
Viruses, Infections, and Depletion
The LCMV-WE and the mutant strain LCMV-WE8.7 (LCMV8.7) (Pircher et al.,
1990) were provided by Dr. R.M. Zinkernagel (University Hospital, Zurich,
Switzerland) and propagated at a lowmultiplicity of infection on L929 fibroblast
cells. Recombinant VSV expressing the LCMV glycoprotein (VSVGP) was
grown on L292 cells. Recombinant Vaccinia virus expressing the LCMV
glycoprotein (VVG2) was originally obtained from Dr. D.H.L. Bishop (Oxford
University) and was grown on BSC40 cells at low multiplicity of infection.
Coinfection of LCMV8.7 and VVG2 was performed by intraperitoneal (i.p.)
injection of 1 3 104 ffu LCMV8.7 and 5 3 106 pfu VVG2. Infections with 200
ffu LCMV-WE or 2 3 106 pfu VSVGP were performed intravenously (i.v.).
Infection with 5 3 106 pfu VVGP was performed i.p.
Depletion of NK cells with either aNK1.1 (clone PK136, Bio X cell) or anti-
Asialo GM1 (wako chem) was performed by i.p injection of 300 mg aNK1.1 or
10 ml anti-Asialo GM1 1 day before and after infection.
Adoptive Transfer
CD8+ andCD4+ T cells were isolated from naive P14 or SM (Ly5.1+) or Ifnar1/
P14 or SM (Thy1.1+) mice using anti-CD8 or anti-CD4 beads (Miltenyi Biotech)
and adoptively cotransferred into naive recipient mice. To study the function-
ality of memory P14 cells, we isolated lymphocytes 80 days p.i. and purified a
total of 106 CD8+ T cells by anti-CD8 MACS beads and transferred them into
naive recipient mice. Prior to transfer, the frequency of memory WT and
Ifnar1/ P14 cells among the total CD8+ T cells was determined by flow
cytometry.
Flow Cytometry
Staining was performed on whole-blood or single-cell suspensions from the
indicated organs. All fluorescent antibodies used were purchased from
BioLegend, eBioscience, or BD Biosciences. NCR1-IgG fusion protein was a
kind gift from Professor Mandelboim and was described previously (Mandel-
boim et al., 2001). Data were acquired on a LSRII flow cytometer (BD
Bioscience) and analyzed with Flowjo software (Treestar).
Microarray
WT and Ifnar1/ P14 T cells were isolated from day 3 LCMV8.7 + VVG2
co-infected mice that were undepleted or depleted of NK cells. T cells were
sorted to purity by flow cytometry. Microarray analysis was performed by
Miltenyi Biotec and data analysis was done in collaboration with the Vital-ITImmunity 40, 961–973, June 19, 2014 ª2014 Elsevier Inc. 971
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NK Cells Kill Ifnar1/ T CellsGroup, SIB Swiss Institute of Bioinformatics (Supplemental Experimental
Procedures).
In Vivo Killer Assay
Activated T cells were isolated from VVG2 and LCMV8.7 coinfected mice
following adoptive cotransfer of 106 WT and Ifnar1/ P14 cells at day 3 p.i.
CD8+ T cells wereMACSpurified and adoptively transferred into naive or infec-
tion-matched hosts. Following 6 hr incubation, spleens were isolated and
analyzed by flow cytometry. The recovery of P14 cells from infected hosts
was normalized to the number recovered in the naive hosts.
Ex Vivo Killer Assay
Activated NK cells were isolated from day 2 post LCMV (106 ffu)-infected mice
by DX5 MACS bead purification. NK cells were added to round bottom 96 well
plates together with the indicated blocking antibodies (Supplemental Experi-
mental Procedures). Activated T cells were isolated from VVG2 and
LCMV8.7 coinfected mice following adoptive transfer of WT and Ifnar1/
P14 cells at day 3 p.i. Activated T cells were FACS sorted to purity based on
the expression of CD8 and Ly5.1 (WT) or Thy1.1 (Ifnar1/ P14). We added
2 3 104 purified P14 or Ifnar1/ T cells to the 96 well plates separately.
Following a 6 hr incubation, T cells were stained with 7-AAD and Annexin V
according to manufactures recommendation.
Quantitative Real-Time PCR
Total RNA was isolated from sorted P14 T cells 3 days after LCMV8.7 + VVG2
coinfection of NK-cell-depleted mice. RNA was isolated with TRIzol
(Invitrogen) according to the manufacturer’s instructions, and cDNA was
reverse transcribed with M-MLV reverse transcriptase RNase, Hminus (Prom-
ega). Real-time PCRwas performedwith Rotorgene 3000 (Corbett). qPCRwas
performed with TaqMan probes for the indicated genes together with GAPDH
as internal control. Analysis was performed by determining the Ct value for
each sample normalized toGAPDH (DCt). Fold expression was then calculated
with the DDCt method, briefly DCt from Ifnar1/ P14 cells was subtracted
from the DCt of WT P14 cells giving a DDCt. Fold induction was calculated
with the Equation 2-DDCt.
Statistical Analysis
Statistical significance was determined by a two-tailed unpaired t test with
GraphPad Prism.
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